Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Grassley And Baucus Turn Up Heat On GSK With Attack On Avandia Data Handling

This article was originally published in The Pink Sheet Daily

Executive Summary

Company's internal e-mails suggest GSK hid vital studies related to safety of Avandia relative to competitor, senators charge.
Advertisement

Related Content

Ingredients For Product Liability Litigation: From FDA Actions To Foreign Labels
Ingredients For Product Liability Litigation: From FDA Actions To Foreign Labels
Avandia Advisory Committee Re-Review Reflects Well On FDA
Avandia Advisory Committee Re-Review Reflects Well On FDA
Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.
Arava, Avandia's Divergent Paths: FDA Strengthens Arava Label Warning
Avandia Day Two Might Be Same Old Song Even With Broken RECORD
GSK Settles Hundreds Of Avandia Suits Before FDA Advisory Cmte. Meeting
Grassley Wants An Rx Safety Reorganization; Can FDA Keep Him At Bay Again? Congressional Avandia Investigation Reopens Door On Splitting CDER
Grassley Wants An Rx Safety Reorganization; Can FDA Keep Him At Bay Again? Congressional Avandia Investigation Reopens Door On Splitting CDER

Topics

Advertisement
UsernamePublicRestriction

Register

PS070885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel